App and website aim to ease perinatal depression care

NCT ID NCT05525689

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a technology service to help care managers in obstetrics clinics treat depression during pregnancy and after birth. 75 women with moderate to severe depression used an app for symptom tracking and a website with educational content. The goal was to see if these tools improve depression and anxiety outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

IntelliCare app and COMPASS-Care website

What this could lead to

If successful, this could show that technology tools help care managers better treat depression during and after pregnancy.

What could go wrong

This is a small, completed study with 75 participants, so results may not apply to everyone. It tested a service, not a new drug, so the impact is limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder perinatal asphyxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Prentice Women's Hospital

    Chicago, Illinois, 60611, United States